Skip to main content
  • Register
  • Help
  • Contact us
  • Log out of your HL account

Baillie Gifford US Growth Trust (USA) Ordinary Shares

Sell:133.00p Buy:134.00p 0 Change: 0.50p (0.37%)
Market closed Prices as at close on 3 April 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:133.00p
Buy:134.00p
Change: 0.50p (0.37%)
Market closed Prices as at close on 3 April 2020 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:133.00p
Buy:134.00p
Change: 0.50p (0.37%)
Market closed Prices as at close on 3 April 2020 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Objective

The Company will invest predominantly in equities of companies which are incorporated or domiciled, or which conduct a significant portion of their business, in the United States and which the Company believes have the potential to grow substantially faster than the average company over the long term. Such investment will typically be direct, but may be indirect, including through investment in funds.

Top 10 holdings currently unavailable.

Sector Weight
Consumer Cyclical 20.60%
Communication Services 16.60%
Technology 14.49%
Healthcare 13.08%
Financial Services 10.73%
Real Estate 3.24%
Industrials 2.64%
Consumer Defensive 2.13%
Country Weight
United States 77.68%
Canada 5.82%

Fee Structure

Management fee of 0.7% p.a. of the NAV up to and including GBP 100m plus 0.55% p.a. of the NAV exceeding GBP 100m. Agreement terminable on notice period of six months.

Dividend Policy

The Company will have no dividend target and will not seek to provide Shareholders with a particular level of distribution. The Company will distribute amounts such that it does not retain in respect of an accounting period an amount greater than 15% of its income for that period. It is not currently envisaged that any dividend will be paid in the foreseeable future.

ASSET SPLIT

Total number of holdings: 0.

Trust Manager

Gary Robinson

Manager Bio

Gary Robinson, CFA, Partner, Investment Manager, U.S. Equities Team at Baillie Gifford. He graduated MBiochem in Biochemistry from the University of Oxford in 2003 and joined Baillie Gifford the same year. He spent time working on our Japanese, UK and European equity teams before moving to the US Equities Team in 2008. Gary is a generalist investor but retains a special interest in the healthcare sector dating back to his undergraduate degree. Gary is a portfolio manager for our Global Select strategy.

Board Of Directors

Tom BurnetChairman, Graham Paterson, Susan Inglis

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.